Back
Gartner, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Buy
53
IT
Gartner, Inc.
Last Price:
$233.84
Seasonality Move:
1.89%
Sell
48
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$36.24
Seasonality Move:
6.21%
Buy
53
Gartner, Inc. (IT)
is a Buy
Is Gartner, Inc. a Buy, Sell or Hold?
-
The current Gartner, Inc. [IT] share price is $233.89. The Score for IT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
IT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IT Stock Price Chart
What is Gartner, Inc.'s stock price today?
-
The Gartner, Inc. share price today is $233.89The current trend is relatively stagnant and IT is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $36.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
IT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.61 | Sell |
| Relative Strength Index (14 RSI): | 51.16 | Buy |
| Chaikin Money Flow: | -2498 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (227.6 - 232.9) | Buy |
| Bollinger Bands (100): | (220.19 - 280.23) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 61.17 | Buy |
| Chaikin Money Flow: | -31475 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.18 - 35.78) | Buy |
| Bollinger Bands (100): | (28.77 - 33.95) | Buy |
IT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 230.98 | Buy |
| 20-day SMA: | 230.27 | Buy |
| 50-day SMA: | 237.7 | Sell |
| 200-day SMA: | 334.93 | Sell |
| 8-day EMA: | 231.4 | Buy |
| 20-day EMA: | 231.86 | Buy |
| 50-day EMA: | 239.8 | Sell |
| 200-day EMA: | 318.17 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.32 | Sell |
| 20-day SMA: | 34.36 | Buy |
| 50-day SMA: | 33.41 | Buy |
| 200-day SMA: | 33.75 | Buy |
| 8-day EMA: | 35.88 | Buy |
| 20-day EMA: | 34.85 | Buy |
| 50-day EMA: | 33.54 | Buy |
| 200-day EMA: | 34.8 | Buy |
Gartner, Inc. Earnings Growth & IT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $0.68 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Gartner, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||